Prognostic value of tumor‑infiltrating lymphocytes in estrogen receptor‑positive and human epidermal growth factor receptor 2‑negative breast cancer | Zendy

Chikako Honda | Zendy; Sasagu Kurozumi | Zendy; Ayaka Katayama | Zendy; Bishoy HannaKhalil | Zendy; Kei Masuda | Zendy; Yuko Nakazawa | Zendy; Misato Ogino | Zendy; Sayaka Obayashi | Zendy; Reina Yajima | Zendy; Takaya Makiguchi | Zendy; Tetsunari Oyama | Zendy; Jun Horiguchi | Zendy; Ken Shirabe | Zendy; Takaaki Fujii | Zendy

Open Access

Prognostic value of tumor‑infiltrating lymphocytes in estrogen receptor‑positive and human epidermal growth factor receptor 2‑negative breast cancer

Author(s) -

Chikako Honda,

Sasagu Kurozumi,

Ayaka Katayama,

Bishoy HannaKhalil,

Kei Masuda,

Yuko Nakazawa,

Misato Ogino,

Sayaka Obayashi,

Reina Yajima,

Takaya Makiguchi,

Tetsunari Oyama,

Jun Horiguchi,

Ken Shirabe,

Takaaki Fujii

Publication year - 2021

Publication title -

molecular and clinical oncology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.442

H-Index - 7

eISSN - 2049-9469

pISSN - 2049-9450

DOI - 10.3892/mco.2021.2414

Subject(s) - breast cancer , tumor infiltrating lymphocytes , estrogen receptor , cancer , oncology , medicine , oncogene , triple negative breast cancer , progesterone receptor , stromal cell , estrogen , epidermal growth factor receptor , cancer research , pathology , cell cycle , immunotherapy

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research